Joint association of atherogenic index of plasma and body roundness index with incident cardiovascular desease: a prospective cohort study
This prospective cohort study of 275,172 UK Biobank participants demonstrates that both the atherogenic index of plasma (AIP) and the body roundness index (BRI) are independent, linearly associated risk factors for incident cardiovascular disease, with the highest risk observed in individuals exhibiting elevated levels of both markers.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Heart disease remains the leading cause of death across the globe, a relentless force that has claimed more lives and affected more people in the last two decades than ever before. While doctors have long known that high blood pressure, smoking, and poor diet drive this risk, the search for better ways to spot danger early continues. Two specific measurements have recently moved to the forefront of this search. The first is a calculation based on blood fats, known as the atherogenic index of plasma. This number compares the amount of triglycerides, a type of fat in the blood, against high-density lipoprotein cholesterol, often called the "good" cholesterol. A higher number here suggests the blood is more prone to forming the sticky plaques that clog arteries. The second measurement is the body roundness index. Unlike the standard body mass index, which only weighs a person against their height, this calculation uses waist size and height to estimate how much fat is stored deep inside the belly, around the organs. This visceral fat is particularly dangerous because it acts like a factory for inflammation and metabolic trouble. Understanding how these two distinct factors—blood chemistry and body shape—work together could offer a clearer picture of who is truly at risk.
A team of researchers set out to explore this connection using data from the UK Biobank, a massive health study that has followed hundreds of thousands of volunteers for years. They focused on 275,172 adults who were healthy enough to have no history of heart disease, stroke, or heart failure when the study began. The scientists wanted to see if these two markers, when viewed alone or in combination, could predict who would develop cardiovascular problems over time. They tracked these individuals for a median of just over 13 years, watching to see who experienced a major heart event, such as a stroke, heart failure, or a blockage in the heart's arteries.
The results painted a clear picture of risk. During the follow-up period, more than 30,000 participants developed cardiovascular disease. When the researchers looked at the data, they found that having high levels of the blood fat index alone increased the risk of heart trouble. Similarly, having a body shape indicating high levels of deep belly fat also raised the risk. However, the most significant danger appeared when both factors were present. People who had both high blood fat levels and high belly fat faced the highest risk of all. Compared to those with low levels of both markers, individuals with high levels of both were 20 percent more likely to develop cardiovascular disease. This risk was not just a simple addition of two bad things; the study showed that the two factors interact in a specific way, where the combined effect is slightly less than what one might expect if they simply multiplied their individual risks, yet the absolute danger for those with both remains the highest.
The researchers also examined how these risks played out across different groups of people. They found that the link between these markers and heart disease held true regardless of age, gender, or background, though the strength of the connection varied slightly. For instance, the association was particularly strong in people under the age of 60 and in those who did not have other major risk factors like diabetes or high blood pressure. This suggests that even people who might seem healthy because they lack traditional warning signs could still be at risk if their blood fat levels and body shape indicate trouble. The study also checked whether the relationship was a straight line or if there was a tipping point where risk suddenly spiked. The data showed a steady, linear increase: as the blood fat index went up, the risk went up; as the body roundness index went up, the risk went up. There was no sudden cliff edge, just a consistent climb in danger as the numbers rose.
To ensure these findings were solid, the team ran the numbers through various tests, removing people who were already taking medication for blood pressure or diabetes, and excluding those with very short follow-up times. The results remained consistent. They also accounted for the possibility that people might die from other causes before a heart event could occur, and the pattern held firm. The study concludes that monitoring both the blood fat index and the body roundness index offers a powerful way to identify high-risk individuals. While the study did not test specific treatments, the authors suggest that targeting these two areas could provide significant public health benefits. By catching people with high levels of both markers early, doctors and individuals might be able to intervene before heart disease takes hold, offering a practical path toward preventing one of the world's most persistent killers.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.